Log In

 
Company : Hiranandani Group 
Monday, January 30, 2017 7:35PM IST (2:05PM GMT)
 
'The Walk' Presents 'Hiranandani Thane Half Marathon 2017' on 12 February, 2017
“Annual fitness conscious event helps create better individuals that in turn create better communities,” says Dr. Niranjan Hiranandani
 
Mumbai, Thane, Maharashtra, India

  • Last date for registration is 31 January, 2017

The fifth edition of the Hiranandani Thane Half Marathon (HTHM) the second most popular run in Maharashtra will be flagged off on Sunday, February 12, 2017 from Hiranandani Estate, Thane. The theme for ‘The Walk’ presents ‘Hiranandani Thane Half Marathon 2017’ is ‘Running for Expression’.
 
“No longer is the individual uni-dimensional. Running is the expression of forbearance and a reflection of one’s conquering spirit,” said Dr. Niranjan Hiranandani, CMD, Hiranandani Communities. “The Hiranandani Thane Half Marathon (HTHM) annual event allows participants to explore their multi-dimensional personalities, helping create better individuals that in turn create better communities,” he added.
 
Espousing the concept of ‘Running for a Cause’, the fifth edition of the Hiranandani Thane Half Marathon, which has been recognized by the Athletics Federation of India, will have four categories. First, the Half Marathon, which will have runners going for 21.097km. The second is the ‘Green Run’, which is 10 kms. Then, the ‘Fun Run’, which is 4 kms. The fourth category will be Half Marathon Pacers. Registration fee collected from participants is donated to a charitable institution doing social work. Substantial charity fund amounting Rs 80lacs was raised in the last year edition; which has been donated to charitable institutions like Ruhi (associated with Tata Memorial Hospital), Jaipur Foot, Mumbai Mobile Creches, Concern India, Oxfam, Buniyaad and Agasthi Foundation. The fund to be raised from current year HTHM would be donated to Akshay Patra Foundation and Rotary Club of Thane North-End.
 
Hiranandani Thane Half Marathon 2017 is an initiative to awaken residents of Thane about the importance of maintaining their health and lifestyle. With busy schedules, work pressure and hectic lifestyles, we see that citizens tend to neglect their health. The ‘Hiranandani Thane Half Marathon 2017’, is a health wake-up call for residents, said Niranjan Hiranandani.
 
“The last date for registration is 31 January, 2017, and I hope running enthusiasts will make it a point to register,” concluded Dr. Niranjan Hiranandani.
 
Please visit: www.hthm.co.in

 
For News Release background on Hiranandani Group click here
 
Media Contact Details
Ritika Shah, Media Manager, Hiranandani Communities, +91-9833461094
 
 
Submit your press release
More News from Hiranandani Group

10/10/2018 12:12PM Image

NAREDCO National President Reaches out to Indian Diaspora in GCC Countries

On 29 September 2018, Dr. Niranjan Hiranandani, who is also co-founder and MD, Hiranandani Group, addressed a media meet in Dubai, United Arab Emirates (UAE), where he re-told the story of India as a nation where ...

04/10/2018 10:00AM Image

NAREDCO Teams up With Ministry of Housing and Urban Affairs, Government of India

NAREDCO (National Real Estate Development Council) has entered into a Memorandum of Understanding (MoU) with the Ministry of Housing & Urban Affairs (MoHUA), Government of India, on 27th September 2018 at Mumbai, ...

21/09/2018 1:05PM Image

Priyadarshni Academy’s 34th Anniversary Global Awards 2018 Honoured Stalwarts Including Actor Anushka Sharma, Entrepreneur Ronnie Screwvala

Priyadarshni Academy’s 34th Anniversary Global Awards was held at Hotel Trident, Nariman Point, on September 19, 2018. The glittering ceremony saw the who's who of India in attendance.

Similar News

20/10/2018 12:30PM

Manchester United and True Religion Launch Denim Range

Iconic Denim Brand Designs Exclusive Club co-Branded Range Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim ...

No Image

20/10/2018 12:20PM

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer

– In Patients with Brain Metastases at Baseline, ALUNBRIG Reduced the Risk of Progression in the Brain or Death by 73 Percent – – Intracranial Efficacy Data Reinforces Superiority of ALUNBRIG Versus ...